|
PSAT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.13299999999306E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.56780000002155E-06 |
| Normal-vs-Stage2 |
3.814200E-04 |
| Normal-vs-Stage3 |
3.023700E-02 |
| Normal-vs-Stage4 |
3.003600E-03 |
| Stage1-vs-Stage2 |
1.628990E-01 |
| Stage1-vs-Stage3 |
8.741200E-03 |
| Stage1-vs-Stage4 |
9.406100E-02 |
| Stage2-vs-Stage3 |
1.350240E-01 |
| Stage2-vs-Stage4 |
6.618400E-01 |
| Stage3-vs-Stage4 |
4.390200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.7076099999902E-05 |
| Normal-vs-AfricanAmerican |
5.79649999999932E-05 |
| Normal-vs-Asian |
1.571030E-01 |
| Caucasian-vs-AfricanAmerican |
3.124800E-01 |
| Caucasian-vs-Asian |
3.484600E-01 |
| AfricanAmerican-vs-Asian |
2.934600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.37379999995713E-06 |
| Normal-vs-Female |
4.975400E-04 |
| Male-vs-Female |
4.823900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.218480E-03 |
| Normal-vs-Extreme_Weight |
1.35440000004206E-06 |
| Normal-vs-Obese |
6.45149999999317E-05 |
| Normal-vs-Extreme_Obese |
2.322200E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.964900E-03 |
| Normal_Weight-vs-Obese |
2.338600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.836400E-01 |
| Extreme_Weight-vs-Obese |
4.831800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.203200E-01 |
| Obese-vs-Extreme_Obese |
6.533000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.130830E-01 |
| Normal-vs-Age(41-60Yrs) |
6.44509999999654E-05 |
| Normal-vs-Age(61-80Yrs) |
2.37160000005066E-06 |
| Normal-vs-Age(81-100Yrs) |
7.856400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.302230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.356100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.341400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.403400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.549400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.558800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.1184999999525E-06 |
| Normal-VS-Type2 PRCC |
3.581800E-04 |
| Normal-VS-KIRP CIMP |
5.470000E-01 |
| Normal-VS-Unclassified PRCC |
2.40689999999599E-05 |
| Type1 PRCC-VS-Type2 PRCC |
9.996100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.448600E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.756120E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.19600000000476E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.618810E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.400300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.16989999999906E-05 |
| Normal-vs-N1 |
5.394400E-02 |
| Normal-vs-N2 |
1.226150E-01 |
| N0-vs-N1 |
2.764400E-02 |
| N0-vs-N2 |
8.916200E-01 |
| N1-vs-N2 |
4.075200E-01 |
|
|
